Opinion: Race alone should not be used to allocate scarce Covid-19 treatments

In hospitals and health care systems, life and death decisions are being made about who should get scarce antiviral medications from Pfizer and Merck and monoclonal antibodies from AstraZeneca and Vir/GSK. These medicines can keep people out of the hospital and save lives.
Given the limited supplies of these medicines, race — along with other variables — is being used to determine who gets them in many states battling the Omicron surge. Hospitals and health care workers are forced to make agonizing triage decisions tantamount to deciding who shall live or die. Read the rest…